The Cgrp Inhibitor Market is on the brink of transformative trends that are set to redefine treatment paradigms by 2035. With a projected market size of $9,645.99 million and a CAGR of 12.33%, the landscape is evolving rapidly to meet the needs of patients suffering from migraine disorders. As healthcare stakeholders increasingly pivot towards innovative solutions, the demand for effective CGRP...